These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 26705040

  • 21. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
    Shi RL, Qu N, Luo TX, Xiang J, Liao T, Sun GH, Wang Y, Wang YL, Huang CP, Ji QH.
    Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
    [Abstract] [Full Text] [Related]

  • 22. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
    Zhan L, Feng HF, Yu XZ, Li LR, Song JL, Tu Y, Yuan JP, Chen C, Sun SR.
    BMC Surg; 2022 Jun 20; 22(1):235. PubMed ID: 35725426
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y, Xu L, Wang J.
    J Surg Res; 2018 Jan 20; 221():128-134. PubMed ID: 29229118
    [Abstract] [Full Text] [Related]

  • 25. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
    Zhang X, Chen W, Fang Q, Fan J, Feng L, Guo L, Liu S, Ge H, Du W.
    Front Endocrinol (Lausanne); 2021 Jan 20; 12():716082. PubMed ID: 34335480
    [Abstract] [Full Text] [Related]

  • 26. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma.
    Liu Z, Li C.
    Clin Hemorheol Microcirc; 2022 Jan 20; 82(4):361-370. PubMed ID: 36213988
    [Abstract] [Full Text] [Related]

  • 27. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I.
    J Clin Pathol; 2011 Apr 20; 64(4):325-9. PubMed ID: 21296795
    [Abstract] [Full Text] [Related]

  • 28. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L, Zhu Y, Zheng K, Zhang H, Guo H, Zhang L, Wu K, Kong L, Ruan W, Hu J, Zhang X, Chen X.
    J Cancer Res Clin Oncol; 2017 Jun 20; 143(6):1035-1042. PubMed ID: 28204971
    [Abstract] [Full Text] [Related]

  • 29. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N, Jiang R, Yang JY, Tang C, Yang L, Xu M, Jiang QF, Liu ZM.
    J Mol Histol; 2014 Aug 20; 45(4):391-9. PubMed ID: 24276590
    [Abstract] [Full Text] [Related]

  • 30. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N, Tastekin E, Ozyilmaz F, Sezer YA, Guldiken S, Sut N, Sarikas N, Oz Puyan F, Guler B, Ayturk S, Celik M.
    Endocr Pathol; 2015 Sep 20; 26(3):218-28. PubMed ID: 26209182
    [Abstract] [Full Text] [Related]

  • 31. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J, Wang X, Zhang X, Li P, Hou H.
    Diagn Pathol; 2015 Jul 14; 10():96. PubMed ID: 26168921
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Predictive factors of lymph node metastasis in papillary thyroid cancer.
    Song WJ, Um IC, Kwon SR, Lee JH, Lim HW, Jeong YU, Chung SM, Moon JS, Yoon JS, Won KC, Lee HW.
    PLoS One; 2023 Jul 14; 18(11):e0294594. PubMed ID: 38011178
    [Abstract] [Full Text] [Related]

  • 34. [The characteristic of metabolics of female papillary thyroid carcinoma and its relationship with primary tumor size and cervical lymph node metastases].
    Zheng WJ, Xu YN, Zhou QY, Chen J, Fei MJ, Wang JD.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb 14; 51(2):105-11. PubMed ID: 26898866
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Papillary thyroid carcinoma involving cervical neck lymph nodes: correlations with lymphangiogenesis and ultrasound features.
    Choi Y, Park KJ, Ryu S, Kim DH, Yun J, Kang DK, Chun M.
    Endocr J; 2012 Feb 14; 59(10):941-8. PubMed ID: 22785182
    [Abstract] [Full Text] [Related]

  • 37. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
    Kim SK, Park I, Woo JW, Lee JH, Choe JH, Kim JH, Kim JS.
    Thyroid; 2017 Feb 14; 27(2):207-214. PubMed ID: 27750022
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
    Wang N, Dong CR, Jiang R, Tang C, Yang L, Jiang QF, Chen GG, Liu ZM.
    Int J Clin Exp Pathol; 2014 Feb 14; 7(1):322-30. PubMed ID: 24427353
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for posterior to right recurrent laryngeal nerve lymph node metastasis in papillary thyroid carcinoma.
    Zhang DG, Gao L, Miao YW, He GF, Xie L.
    Saudi Med J; 2014 Aug 14; 35(8):832-7. PubMed ID: 25129182
    [Abstract] [Full Text] [Related]

  • 40. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM.
    Clin Cancer Res; 2005 Nov 15; 11(22):8063-9. PubMed ID: 16299237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.